

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of cell size (GO:0045793) | 7.90864597 |
| 2 | diaphragm development (GO:0060539) | 6.96440805 |
| 3 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 6.72071613 |
| 4 | arginine catabolic process (GO:0006527) | 6.59742745 |
| 5 | pyrimidine-containing compound salvage (GO:0008655) | 6.33521974 |
| 6 | pyrimidine nucleoside salvage (GO:0043097) | 6.33521974 |
| 7 | skeletal muscle organ development (GO:0060538) | 5.87384383 |
| 8 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 5.69598792 |
| 9 | cellular protein complex localization (GO:0034629) | 5.67144187 |
| 10 | response to lipoprotein particle (GO:0055094) | 5.66103463 |
| 11 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 5.62284955 |
| 12 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 5.53911103 |
| 13 | UMP metabolic process (GO:0046049) | 5.53911103 |
| 14 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 5.53911103 |
| 15 | UMP biosynthetic process (GO:0006222) | 5.53911103 |
| 16 | negative regulation of neurotransmitter transport (GO:0051589) | 5.51730631 |
| 17 | arginine metabolic process (GO:0006525) | 5.20393732 |
| 18 | exogenous drug catabolic process (GO:0042738) | 5.10723834 |
| 19 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 5.01751763 |
| 20 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.90145401 |
| 21 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 4.71542931 |
| 22 | negative regulation of vascular permeability (GO:0043116) | 4.71196121 |
| 23 | activation of MAPKKK activity (GO:0000185) | 4.62013433 |
| 24 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 4.60294741 |
| 25 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 4.41373686 |
| 26 | nucleotide salvage (GO:0043173) | 4.34853176 |
| 27 | L-phenylalanine catabolic process (GO:0006559) | 4.33526165 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.33526165 |
| 29 | intestinal cholesterol absorption (GO:0030299) | 4.33356733 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.23464682 |
| 31 | L-phenylalanine metabolic process (GO:0006558) | 4.23464682 |
| 32 | negative regulation of potassium ion transport (GO:0043267) | 4.17442760 |
| 33 | histone H3-K4 methylation (GO:0051568) | 4.13570106 |
| 34 | negative regulation of granulocyte differentiation (GO:0030853) | 4.09983413 |
| 35 | hypotonic response (GO:0006971) | 4.07556018 |
| 36 | nucleoside salvage (GO:0043174) | 4.06254203 |
| 37 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 4.05349052 |
| 38 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 4.03508923 |
| 39 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.99554337 |
| 40 | aromatic amino acid family catabolic process (GO:0009074) | 3.92110364 |
| 41 | drug catabolic process (GO:0042737) | 3.90724952 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.89160358 |
| 43 | protein carboxylation (GO:0018214) | 3.89160358 |
| 44 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.87896123 |
| 45 | urea cycle (GO:0000050) | 3.82687882 |
| 46 | urea metabolic process (GO:0019627) | 3.82687882 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.82270235 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.82270235 |
| 49 | sulfur amino acid catabolic process (GO:0000098) | 3.79899685 |
| 50 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.79883549 |
| 51 | Rap protein signal transduction (GO:0032486) | 3.79114111 |
| 52 | negative regulation of alcohol biosynthetic process (GO:1902931) | 3.75857749 |
| 53 | nerve growth factor signaling pathway (GO:0038180) | 3.71306820 |
| 54 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 3.68681601 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.67683166 |
| 56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.62357064 |
| 57 | complement activation, alternative pathway (GO:0006957) | 3.58836952 |
| 58 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.58408853 |
| 59 | regulation of mRNA catabolic process (GO:0061013) | 3.57799913 |
| 60 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.56319982 |
| 61 | valine metabolic process (GO:0006573) | 3.55896969 |
| 62 | cysteine metabolic process (GO:0006534) | 3.55281590 |
| 63 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.52374730 |
| 64 | positive regulation of receptor biosynthetic process (GO:0010870) | 3.51878286 |
| 65 | indole-containing compound catabolic process (GO:0042436) | 3.51877887 |
| 66 | indolalkylamine catabolic process (GO:0046218) | 3.51877887 |
| 67 | tryptophan catabolic process (GO:0006569) | 3.51877887 |
| 68 | regulation of guanylate cyclase activity (GO:0031282) | 3.47002355 |
| 69 | nitric oxide biosynthetic process (GO:0006809) | 3.46862580 |
| 70 | nitrogen cycle metabolic process (GO:0071941) | 3.46421346 |
| 71 | tryptophan metabolic process (GO:0006568) | 3.45625223 |
| 72 | kynurenine metabolic process (GO:0070189) | 3.45306336 |
| 73 | RNA stabilization (GO:0043489) | 3.45109547 |
| 74 | mRNA stabilization (GO:0048255) | 3.45109547 |
| 75 | alpha-linolenic acid metabolic process (GO:0036109) | 3.44261607 |
| 76 | negative regulation of macrophage differentiation (GO:0045650) | 3.43272325 |
| 77 | negative regulation of protein kinase B signaling (GO:0051898) | 3.42339246 |
| 78 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 3.41455321 |
| 79 | negative regulation of fibrinolysis (GO:0051918) | 3.39214891 |
| 80 | positive regulation of mRNA catabolic process (GO:0061014) | 3.39072602 |
| 81 | homocysteine metabolic process (GO:0050667) | 3.38019623 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.37659015 |
| 83 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.33953604 |
| 84 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.29740360 |
| 85 | high-density lipoprotein particle remodeling (GO:0034375) | 3.29740247 |
| 86 | regulation of gamma-delta T cell activation (GO:0046643) | 3.29622837 |
| 87 | glyoxylate metabolic process (GO:0046487) | 3.28526212 |
| 88 | protein complex localization (GO:0031503) | 3.27442836 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.25946179 |
| 90 | regulation of protein activation cascade (GO:2000257) | 3.25490745 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.24790740 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.22508294 |
| 93 | regulation of protein deacetylation (GO:0090311) | 3.22199467 |
| 94 | bile acid biosynthetic process (GO:0006699) | 3.21472361 |
| 95 | adenine nucleotide transport (GO:0051503) | 3.19303879 |
| 96 | protein heterotrimerization (GO:0070208) | 3.17589483 |
| 97 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.17087021 |
| 98 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.16072152 |
| 99 | bile acid metabolic process (GO:0008206) | 3.13387150 |
| 100 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.09808336 |
| 101 | response to nerve growth factor (GO:1990089) | 3.09808336 |
| 102 | phospholipid efflux (GO:0033700) | 3.09768164 |
| 103 | complement activation (GO:0006956) | 3.07755375 |
| 104 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.05944616 |
| 105 | regulation of complement activation (GO:0030449) | 3.05552576 |
| 106 | plasma lipoprotein particle assembly (GO:0034377) | 3.05323409 |
| 107 | plasma lipoprotein particle clearance (GO:0034381) | 3.04351292 |
| 108 | regulation of neurotransmitter uptake (GO:0051580) | 3.02773212 |
| 109 | regulation of fibrinolysis (GO:0051917) | 3.02677473 |
| 110 | reverse cholesterol transport (GO:0043691) | 3.01729149 |
| 111 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.01433360 |
| 112 | cholesterol efflux (GO:0033344) | 3.01209673 |
| 113 | regulation of triglyceride catabolic process (GO:0010896) | 2.98543291 |
| 114 | proline biosynthetic process (GO:0006561) | 2.97007559 |
| 115 | positive regulation of histone acetylation (GO:0035066) | 2.95221001 |
| 116 | negative regulation of sterol transport (GO:0032372) | 2.94846726 |
| 117 | negative regulation of cholesterol transport (GO:0032375) | 2.94846726 |
| 118 | regulation of stem cell maintenance (GO:2000036) | 2.92912910 |
| 119 | positive regulation of Rap GTPase activity (GO:0032854) | 2.92631368 |
| 120 | protein-lipid complex assembly (GO:0065005) | 2.90936887 |
| 121 | serine family amino acid catabolic process (GO:0009071) | 2.90802941 |
| 122 | negative regulation of interleukin-2 production (GO:0032703) | 2.88958910 |
| 123 | detection of bacterium (GO:0016045) | 2.87976908 |
| 124 | inactivation of MAPK activity (GO:0000188) | 2.87644700 |
| 125 | acylglycerol homeostasis (GO:0055090) | 2.87191647 |
| 126 | triglyceride homeostasis (GO:0070328) | 2.87191647 |
| 127 | tyrosine metabolic process (GO:0006570) | 2.87182196 |
| 128 | regulation of cholesterol homeostasis (GO:2000188) | 2.85489572 |
| 129 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.85417607 |
| 130 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.84353771 |
| 131 | macromolecular complex remodeling (GO:0034367) | 2.84207866 |
| 132 | plasma lipoprotein particle remodeling (GO:0034369) | 2.84207866 |
| 133 | protein-lipid complex remodeling (GO:0034368) | 2.84207866 |
| 134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.81438848 |
| 135 | aromatic amino acid family metabolic process (GO:0009072) | 2.81403922 |
| 136 | detection of other organism (GO:0098543) | 2.80145712 |
| 137 | chromatin silencing (GO:0006342) | 2.77172962 |
| 138 | response to interleukin-15 (GO:0070672) | 2.76158404 |
| 139 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.74707148 |
| 140 | bile acid and bile salt transport (GO:0015721) | 2.74162628 |
| 141 | negative thymic T cell selection (GO:0045060) | 2.74018857 |
| 142 | embryonic process involved in female pregnancy (GO:0060136) | 2.72982401 |
| 143 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.72246787 |
| 144 | glycine metabolic process (GO:0006544) | 2.72114775 |
| 145 | cellular modified amino acid catabolic process (GO:0042219) | 2.72058573 |
| 146 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.72040749 |
| 147 | 4-hydroxyproline metabolic process (GO:0019471) | 2.71428261 |
| 148 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.71187366 |
| 149 | protein activation cascade (GO:0072376) | 2.70977422 |
| 150 | regulation of monocyte differentiation (GO:0045655) | 2.70830798 |
| 151 | regulation of cilium assembly (GO:1902017) | 2.70294282 |
| 152 | protein localization to endosome (GO:0036010) | 2.69225798 |
| 153 | B cell receptor signaling pathway (GO:0050853) | 2.66224754 |
| 154 | phagosome maturation (GO:0090382) | 2.63176823 |
| 155 | protein retention in ER lumen (GO:0006621) | 2.63097374 |
| 156 | regulation of granulocyte differentiation (GO:0030852) | 2.61538369 |
| 157 | COPI coating of Golgi vesicle (GO:0048205) | 2.60784584 |
| 158 | Golgi transport vesicle coating (GO:0048200) | 2.60784584 |
| 159 | immunoglobulin mediated immune response (GO:0016064) | 2.60609726 |
| 160 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.60363746 |
| 161 | purine ribonucleotide transport (GO:0015868) | 2.60277385 |
| 162 | negative T cell selection (GO:0043383) | 2.60221703 |
| 163 | lipoprotein metabolic process (GO:0042157) | 2.60070019 |
| 164 | regulation of cell size (GO:0008361) | 2.59733913 |
| 165 | plasma lipoprotein particle organization (GO:0071827) | 2.59728084 |
| 166 | regulation of cholesterol storage (GO:0010885) | 2.59398515 |
| 167 | low-density lipoprotein particle clearance (GO:0034383) | 2.58563170 |
| 168 | intestinal absorption (GO:0050892) | 2.58498688 |
| 169 | cholesterol homeostasis (GO:0042632) | 2.58139307 |
| 170 | ncRNA 3-end processing (GO:0043628) | 2.57656266 |
| 171 | regulation of cholesterol esterification (GO:0010872) | 2.57341458 |
| 172 | acute-phase response (GO:0006953) | 2.56896869 |
| 173 | establishment of endothelial barrier (GO:0061028) | 2.56509312 |
| 174 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.56206633 |
| 175 | sterol homeostasis (GO:0055092) | 2.56145203 |
| 176 | cytolysis (GO:0019835) | 2.56001169 |
| 177 | serine family amino acid metabolic process (GO:0009069) | 2.55413583 |
| 178 | positive regulation of cell junction assembly (GO:1901890) | 2.55335522 |
| 179 | protein-lipid complex subunit organization (GO:0071825) | 2.54316254 |
| 180 | ethanol oxidation (GO:0006069) | 2.53737854 |
| 181 | cholesterol transport (GO:0030301) | 2.53087887 |
| 182 | sterol transport (GO:0015918) | 2.53087887 |
| 183 | mannose metabolic process (GO:0006013) | 2.52973177 |
| 184 | proline metabolic process (GO:0006560) | 2.52290845 |
| 185 | serine family amino acid biosynthetic process (GO:0009070) | 2.52007553 |
| 186 | benzene-containing compound metabolic process (GO:0042537) | 2.51863919 |
| 187 | COPII vesicle coating (GO:0048208) | 2.51527968 |
| 188 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51064018 |
| 189 | modulation by symbiont of host defense response (GO:0052031) | 2.51064018 |
| 190 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51064018 |
| 191 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51064018 |
| 192 | modulation by symbiont of host immune response (GO:0052553) | 2.51064018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.66606570 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.60195754 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 5.33741760 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.30315932 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.20037288 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.96147941 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.53766996 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.27522351 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.99797894 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.75475609 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.73143818 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.66670498 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.65496142 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.65216683 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.60268620 |
| 16 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.53914076 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.51690160 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.48934322 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.42211270 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40260034 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31445218 |
| 22 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30237698 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.21147672 |
| 24 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.20309120 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.18564205 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.16246753 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13626985 |
| 28 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11009606 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.08212754 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.03545414 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.99425351 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.99408117 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.98244511 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91663630 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89463718 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.86873216 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.80715449 |
| 38 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.77225699 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.73936449 |
| 40 | * MAF_26560356_Chip-Seq_TH1_Human | 1.68201596 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67219499 |
| 42 | * MYB_26560356_Chip-Seq_TH2_Human | 1.67066880 |
| 43 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.66153048 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65259510 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.64113927 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63897361 |
| 47 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.61388284 |
| 48 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58863266 |
| 49 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58064407 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56495471 |
| 51 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.54361733 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51507397 |
| 53 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.51018680 |
| 54 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.49093258 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47920882 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47568233 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47190945 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43879973 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40190366 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36842207 |
| 61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35505412 |
| 62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34965174 |
| 63 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.34674936 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33634347 |
| 65 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32745122 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27948082 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20705349 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18928006 |
| 69 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18828830 |
| 70 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.17877123 |
| 71 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16552424 |
| 72 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16050427 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13893165 |
| 74 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13855849 |
| 75 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13498890 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13310582 |
| 77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12101435 |
| 78 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.10315230 |
| 79 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09988298 |
| 80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09909725 |
| 81 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.09708110 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08802674 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08182415 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08012691 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06698016 |
| 86 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.06051011 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05918240 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.04244913 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04137675 |
| 90 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03545115 |
| 91 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03492598 |
| 92 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01535302 |
| 93 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01445994 |
| 94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00266840 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00264363 |
| 96 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.00055237 |
| 97 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99874075 |
| 98 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98743660 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98656978 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97786591 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97119771 |
| 102 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97016818 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96242636 |
| 104 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.95939963 |
| 105 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.95546515 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95421032 |
| 107 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95303339 |
| 108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95246507 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94559147 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94475329 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92024397 |
| 112 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91865442 |
| 113 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91177167 |
| 114 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90474941 |
| 115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88193099 |
| 116 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87327400 |
| 117 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87147920 |
| 118 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86953060 |
| 119 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85648471 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84633905 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84601739 |
| 122 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84330744 |
| 123 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84330744 |
| 124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83779910 |
| 125 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83489618 |
| 126 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83317735 |
| 127 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.82947275 |
| 128 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.82554026 |
| 129 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82234614 |
| 130 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81830658 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81169413 |
| 132 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80872159 |
| 133 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78025455 |
| 134 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.77061365 |
| 135 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.77057690 |
| 136 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.76903254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.89950857 |
| 2 | MP0000566_synostosis | 5.02850106 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.21780934 |
| 4 | MP0005365_abnormal_bile_salt | 4.18172865 |
| 5 | MP0005360_urolithiasis | 4.00095427 |
| 6 | MP0002234_abnormal_pharynx_morphology | 3.64490836 |
| 7 | MP0005167_abnormal_blood-brain_barrier | 3.60213796 |
| 8 | MP0004233_abnormal_muscle_weight | 3.55135181 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.47416004 |
| 10 | MP0004043_abnormal_pH_regulation | 3.43320202 |
| 11 | MP0010368_abnormal_lymphatic_system | 3.37778101 |
| 12 | MP0005645_abnormal_hypothalamus_physiol | 3.26033900 |
| 13 | MP0004858_abnormal_nervous_system | 3.20152641 |
| 14 | MP0003045_fibrosis | 2.85871717 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.53096849 |
| 16 | MP0002009_preneoplasia | 2.53012911 |
| 17 | MP0005083_abnormal_biliary_tract | 2.49410936 |
| 18 | MP0003252_abnormal_bile_duct | 2.43971341 |
| 19 | MP0009840_abnormal_foam_cell | 2.33344833 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.32645541 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 2.22384188 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.22373848 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.21898176 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.16334415 |
| 25 | MP0010329_abnormal_lipoprotein_level | 2.03682744 |
| 26 | MP0004084_abnormal_cardiac_muscle | 2.03641699 |
| 27 | MP0003436_decreased_susceptibility_to | 2.03308533 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.95609577 |
| 29 | MP0009053_abnormal_anal_canal | 1.94705898 |
| 30 | MP0003303_peritoneal_inflammation | 1.94246207 |
| 31 | MP0000685_abnormal_immune_system | 1.89523584 |
| 32 | MP0006082_CNS_inflammation | 1.87627431 |
| 33 | MP0000609_abnormal_liver_physiology | 1.78899419 |
| 34 | MP0005387_immune_system_phenotype | 1.72703931 |
| 35 | MP0001790_abnormal_immune_system | 1.72703931 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.68711678 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.68183868 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.67567281 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.67474818 |
| 40 | MP0001800_abnormal_humoral_immune | 1.66909112 |
| 41 | MP0005671_abnormal_response_to | 1.66393095 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.62954560 |
| 43 | MP0002419_abnormal_innate_immunity | 1.56001626 |
| 44 | MP0002006_tumorigenesis | 1.53360178 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.51281307 |
| 46 | MP0004947_skin_inflammation | 1.49650132 |
| 47 | MP0003283_abnormal_digestive_organ | 1.47924586 |
| 48 | MP0005025_abnormal_response_to | 1.47620678 |
| 49 | MP0009785_altered_susceptibility_to | 1.46340087 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.45689140 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.45568250 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.44218121 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.43503992 |
| 54 | MP0003868_abnormal_feces_composition | 1.40784499 |
| 55 | MP0001919_abnormal_reproductive_system | 1.40694774 |
| 56 | MP0002723_abnormal_immune_serum | 1.39885813 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.39445254 |
| 58 | MP0009278_abnormal_bone_marrow | 1.37241661 |
| 59 | MP0004883_abnormal_blood_vessel | 1.35499384 |
| 60 | MP0000467_abnormal_esophagus_morphology | 1.34912862 |
| 61 | MP0005332_abnormal_amino_acid | 1.34424086 |
| 62 | MP0005220_abnormal_exocrine_pancreas | 1.33250456 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.31525738 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.27896703 |
| 65 | MP0003075_altered_response_to | 1.27549475 |
| 66 | MP0000733_abnormal_muscle_development | 1.27528686 |
| 67 | MP0008469_abnormal_protein_level | 1.27371544 |
| 68 | MP0001819_abnormal_immune_cell | 1.26890126 |
| 69 | MP0002405_respiratory_system_inflammati | 1.26660898 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.19360016 |
| 71 | MP0000767_abnormal_smooth_muscle | 1.18572231 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.17695035 |
| 73 | MP0002398_abnormal_bone_marrow | 1.17383024 |
| 74 | MP0000598_abnormal_liver_morphology | 1.15222380 |
| 75 | MP0000716_abnormal_immune_system | 1.15053993 |
| 76 | MP0003724_increased_susceptibility_to | 1.14079994 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 1.11056551 |
| 78 | MP0004019_abnormal_vitamin_homeostasis | 1.08718794 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 1.08674307 |
| 80 | MP0005166_decreased_susceptibility_to | 1.07732453 |
| 81 | MP0001501_abnormal_sleep_pattern | 1.07702153 |
| 82 | MP0003195_calcinosis | 1.07389334 |
| 83 | MP0002148_abnormal_hypersensitivity_rea | 1.07252733 |
| 84 | MP0002722_abnormal_immune_system | 1.07043281 |
| 85 | MP0001873_stomach_inflammation | 1.06416707 |
| 86 | MP0003183_abnormal_peptide_metabolism | 1.06133179 |
| 87 | MP0005076_abnormal_cell_differentiation | 1.05500333 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 1.04889952 |
| 89 | MP0001545_abnormal_hematopoietic_system | 1.04889952 |
| 90 | MP0009333_abnormal_splenocyte_physiolog | 1.04357188 |
| 91 | MP0001853_heart_inflammation | 1.04348721 |
| 92 | MP0009643_abnormal_urine_homeostasis | 1.03359496 |
| 93 | MP0003718_maternal_effect | 1.03359340 |
| 94 | MP0004036_abnormal_muscle_relaxation | 1.02751923 |
| 95 | MP0000470_abnormal_stomach_morphology | 1.00804521 |
| 96 | MP0009763_increased_sensitivity_to | 0.96747704 |
| 97 | MP0001533_abnormal_skeleton_physiology | 0.96466608 |
| 98 | MP0002429_abnormal_blood_cell | 0.95921661 |
| 99 | MP0010352_gastrointestinal_tract_polyps | 0.95646950 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.95460199 |
| 101 | MP0004484_altered_response_of | 0.95242267 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.95061507 |
| 103 | MP0001879_abnormal_lymphatic_vessel | 0.94262700 |
| 104 | MP0000703_abnormal_thymus_morphology | 0.94139615 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92731250 |
| 106 | MP0000371_diluted_coat_color | 0.92602222 |
| 107 | MP0003448_altered_tumor_morphology | 0.91728295 |
| 108 | MP0009764_decreased_sensitivity_to | 0.91214942 |
| 109 | MP0003091_abnormal_cell_migration | 0.89605488 |
| 110 | MP0008872_abnormal_physiological_respon | 0.88593932 |
| 111 | MP0002168_other_aberrant_phenotype | 0.88340164 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.88331515 |
| 113 | MP0005164_abnormal_response_to | 0.87904938 |
| 114 | MP0001764_abnormal_homeostasis | 0.87767454 |
| 115 | MP0002132_abnormal_respiratory_system | 0.87562938 |
| 116 | MP0006138_congestive_heart_failure | 0.85101920 |
| 117 | MP0005023_abnormal_wound_healing | 0.85091447 |
| 118 | MP0000569_abnormal_digit_pigmentation | 0.84820407 |
| 119 | MP0005310_abnormal_salivary_gland | 0.82908304 |
| 120 | MP0005451_abnormal_body_composition | 0.82673399 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.82472532 |
| 122 | MP0001664_abnormal_digestion | 0.82325430 |
| 123 | MP0002933_joint_inflammation | 0.81864072 |
| 124 | MP0005408_hypopigmentation | 0.80508015 |
| 125 | MP0010307_abnormal_tumor_latency | 0.80220124 |
| 126 | MP0003186_abnormal_redox_activity | 0.79642649 |
| 127 | MP0005174_abnormal_tail_pigmentation | 0.79243840 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.79089515 |
| 129 | MP0002928_abnormal_bile_duct | 0.77522961 |
| 130 | MP0000858_altered_metastatic_potential | 0.77357389 |
| 131 | MP0010678_abnormal_skin_adnexa | 0.76037791 |
| 132 | MP0000604_amyloidosis | 0.76001148 |
| 133 | MP0000490_abnormal_crypts_of | 0.74787243 |
| 134 | MP0001663_abnormal_digestive_system | 0.74413515 |
| 135 | MP0003828_pulmonary_edema | 0.72706614 |
| 136 | MP0004130_abnormal_muscle_cell | 0.72526276 |
| 137 | MP0002998_abnormal_bone_remodeling | 0.72088978 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.71186342 |
| 139 | MP0008260_abnormal_autophagy | 0.70306798 |
| 140 | MP0000383_abnormal_hair_follicle | 0.69171632 |
| 141 | MP0009765_abnormal_xenobiotic_induced | 0.68851759 |
| 142 | MP0000015_abnormal_ear_pigmentation | 0.65469335 |
| 143 | MP0002113_abnormal_skeleton_development | 0.64519098 |
| 144 | MP0005197_abnormal_uvea_morphology | 0.61014008 |
| 145 | MP0004808_abnormal_hematopoietic_stem | 0.58674917 |
| 146 | MP0002127_abnormal_cardiovascular_syste | 0.57088878 |
| 147 | MP0000477_abnormal_intestine_morphology | 0.55340384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lip pit (HP:0100267) | 7.30533566 |
| 2 | Sparse lateral eyebrow (HP:0005338) | 7.14127492 |
| 3 | Anal stenosis (HP:0002025) | 6.33497375 |
| 4 | Abnormality of the fingertips (HP:0001211) | 6.33208342 |
| 5 | Ureteral stenosis (HP:0000071) | 5.58534005 |
| 6 | Depressed nasal tip (HP:0000437) | 5.40596815 |
| 7 | Intestinal fistula (HP:0100819) | 5.26011176 |
| 8 | Ureteral obstruction (HP:0006000) | 5.25995840 |
| 9 | Lower limb hyperreflexia (HP:0002395) | 4.56668770 |
| 10 | Short 5th finger (HP:0009237) | 4.43974013 |
| 11 | Deep venous thrombosis (HP:0002625) | 4.28999893 |
| 12 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 4.04227151 |
| 13 | Myocardial infarction (HP:0001658) | 3.89976712 |
| 14 | Complement deficiency (HP:0004431) | 3.89358488 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.86493875 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.83153387 |
| 17 | Increased CSF protein (HP:0002922) | 3.81197467 |
| 18 | Popliteal pterygium (HP:0009756) | 3.76798997 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.69758904 |
| 20 | Xanthomatosis (HP:0000991) | 3.68068422 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.66351686 |
| 22 | T lymphocytopenia (HP:0005403) | 3.63218112 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 3.62583021 |
| 24 | Joint hemorrhage (HP:0005261) | 3.58055713 |
| 25 | Recurrent viral infections (HP:0004429) | 3.56672787 |
| 26 | Abnormality of T cell number (HP:0011839) | 3.54862773 |
| 27 | Abnormality of B cell number (HP:0010975) | 3.53223353 |
| 28 | B lymphocytopenia (HP:0010976) | 3.53223353 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.53087831 |
| 30 | Fatigue (HP:0012378) | 3.45637402 |
| 31 | Ectropion (HP:0000656) | 3.44167424 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 3.35629177 |
| 33 | Hypobetalipoproteinemia (HP:0003563) | 3.33868272 |
| 34 | Posterior subcapsular cataract (HP:0007787) | 3.32074421 |
| 35 | Hypoplasia of the thymus (HP:0000778) | 3.31277282 |
| 36 | Long palpebral fissure (HP:0000637) | 3.22627481 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 3.20848890 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.19225485 |
| 39 | Abnormality of complement system (HP:0005339) | 3.15673034 |
| 40 | Eczematoid dermatitis (HP:0000976) | 3.14807661 |
| 41 | Vertebral hypoplasia (HP:0008417) | 3.07598468 |
| 42 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.07598468 |
| 43 | Fat malabsorption (HP:0002630) | 3.07225387 |
| 44 | Ectopic kidney (HP:0000086) | 3.03089679 |
| 45 | Recurrent abscess formation (HP:0002722) | 3.00043484 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.95909661 |
| 47 | Hyperlipoproteinemia (HP:0010980) | 2.95695530 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.93548112 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.84267520 |
| 50 | Natal tooth (HP:0000695) | 2.84131635 |
| 51 | Colitis (HP:0002583) | 2.83515659 |
| 52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.79769088 |
| 53 | Pustule (HP:0200039) | 2.77972360 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.75922937 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.75922937 |
| 56 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.73867580 |
| 57 | Gingival bleeding (HP:0000225) | 2.72171180 |
| 58 | Thyroiditis (HP:0100646) | 2.72059949 |
| 59 | Eosinophilia (HP:0001880) | 2.70590118 |
| 60 | Glomerulonephritis (HP:0000099) | 2.63298318 |
| 61 | Recurrent otitis media (HP:0000403) | 2.62167994 |
| 62 | Conjugated hyperbilirubinemia (HP:0002908) | 2.61577500 |
| 63 | Steatorrhea (HP:0002570) | 2.60497396 |
| 64 | Epidermoid cyst (HP:0200040) | 2.59777794 |
| 65 | Abnormality of the periventricular white matter (HP:0002518) | 2.59679903 |
| 66 | Hypolipoproteinemia (HP:0010981) | 2.56834390 |
| 67 | Asymmetry of the thorax (HP:0001555) | 2.56780986 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.56546119 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.56546119 |
| 70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.56546119 |
| 71 | Severe combined immunodeficiency (HP:0004430) | 2.54599760 |
| 72 | Combined immunodeficiency (HP:0005387) | 2.49570752 |
| 73 | Periauricular skin pits (HP:0100277) | 2.49302640 |
| 74 | Preauricular pit (HP:0004467) | 2.49302640 |
| 75 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.46483636 |
| 76 | Abnormal platelet volume (HP:0011876) | 2.46422110 |
| 77 | Menorrhagia (HP:0000132) | 2.45401119 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.45146263 |
| 79 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.44392592 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 2.43357603 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.42967837 |
| 82 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.42588530 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.42198008 |
| 84 | Progressive neurologic deterioration (HP:0002344) | 2.41383115 |
| 85 | Hypercholesterolemia (HP:0003124) | 2.39972036 |
| 86 | Abnormality of T cells (HP:0002843) | 2.39725853 |
| 87 | Narrow palate (HP:0000189) | 2.38526998 |
| 88 | Leiomyosarcoma (HP:0100243) | 2.37125407 |
| 89 | Uterine leiomyosarcoma (HP:0002891) | 2.37125407 |
| 90 | Increased mean platelet volume (HP:0011877) | 2.35879925 |
| 91 | Renal cell carcinoma (HP:0005584) | 2.33339991 |
| 92 | Granulocytopenia (HP:0001913) | 2.30599699 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 2.30269745 |
| 94 | Hypoalphalipoproteinemia (HP:0003233) | 2.29516030 |
| 95 | Recurrent skin infections (HP:0001581) | 2.27920268 |
| 96 | Ketosis (HP:0001946) | 2.27685719 |
| 97 | Esophageal varix (HP:0002040) | 2.27468223 |
| 98 | Bladder neoplasm (HP:0009725) | 2.26142724 |
| 99 | Bladder carcinoma (HP:0002862) | 2.26142724 |
| 100 | Hyperammonemia (HP:0001987) | 2.25018822 |
| 101 | Emphysema (HP:0002097) | 2.22169246 |
| 102 | Mask-like facies (HP:0000298) | 2.18986564 |
| 103 | Abnormality of methionine metabolism (HP:0010901) | 2.18596091 |
| 104 | Periodontitis (HP:0000704) | 2.17008079 |
| 105 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.15873924 |
| 106 | Hypoglycemic coma (HP:0001325) | 2.13939632 |
| 107 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11261346 |
| 108 | Nephritis (HP:0000123) | 2.11250429 |
| 109 | Self-mutilation (HP:0000742) | 2.10445960 |
| 110 | Spontaneous hematomas (HP:0007420) | 2.10308677 |
| 111 | Pheochromocytoma (HP:0002666) | 2.09867758 |
| 112 | Epistaxis (HP:0000421) | 2.09060494 |
| 113 | Hypochromic microcytic anemia (HP:0004840) | 2.05809028 |
| 114 | Wide intermamillary distance (HP:0006610) | 2.03639585 |
| 115 | Meningitis (HP:0001287) | 2.02952352 |
| 116 | Hematochezia (HP:0002573) | 2.02697672 |
| 117 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.02655686 |
| 118 | Neonatal short-limb short stature (HP:0008921) | 2.01787087 |
| 119 | Abnormality of eosinophils (HP:0001879) | 2.00654531 |
| 120 | Hepatocellular carcinoma (HP:0001402) | 1.99988922 |
| 121 | Abnormality of macrophages (HP:0004311) | 1.98997866 |
| 122 | Neonatal death (HP:0003811) | 1.98213430 |
| 123 | Leukocytosis (HP:0001974) | 1.97401865 |
| 124 | Pulmonary infiltrates (HP:0002113) | 1.96252427 |
| 125 | Mitral stenosis (HP:0001718) | 1.96141241 |
| 126 | Agammaglobulinemia (HP:0004432) | 1.94962230 |
| 127 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.93844406 |
| 128 | Thrombophlebitis (HP:0004418) | 1.93469337 |
| 129 | Abnormal foot bone ossification (HP:0010675) | 1.93234896 |
| 130 | Coarse hair (HP:0002208) | 1.92804171 |
| 131 | Pulmonary embolism (HP:0002204) | 1.92762173 |
| 132 | Arterial thrombosis (HP:0004420) | 1.91472922 |
| 133 | Vascular calcification (HP:0004934) | 1.90893793 |
| 134 | Blue irides (HP:0000635) | 1.90445629 |
| 135 | Myositis (HP:0100614) | 1.88575279 |
| 136 | Abnormality of proline metabolism (HP:0010907) | 1.88480024 |
| 137 | Hydroxyprolinuria (HP:0003080) | 1.88480024 |
| 138 | Increased cerebral lipofuscin (HP:0011813) | 1.88236626 |
| 139 | Trismus (HP:0000211) | 1.86958536 |
| 140 | Vasculitis (HP:0002633) | 1.86884212 |
| 141 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85879094 |
| 142 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.85096349 |
| 143 | Hyperglycinuria (HP:0003108) | 1.84356598 |
| 144 | Tubulointerstitial fibrosis (HP:0005576) | 1.82729555 |
| 145 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82409429 |
| 146 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.81738268 |
| 147 | Axonal loss (HP:0003447) | 1.81725806 |
| 148 | Hypochromic anemia (HP:0001931) | 1.81207743 |
| 149 | Gastrointestinal infarctions (HP:0005244) | 1.81091912 |
| 150 | Gingivitis (HP:0000230) | 1.80780414 |
| 151 | Pancreatitis (HP:0001733) | 1.80639682 |
| 152 | Cerebral hemorrhage (HP:0001342) | 1.80621606 |
| 153 | Abnormal platelet function (HP:0011869) | 1.80185012 |
| 154 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.79096860 |
| 155 | Recurrent cutaneous fungal infections (HP:0011370) | 1.79096860 |
| 156 | Gastrointestinal stroma tumor (HP:0100723) | 1.78991647 |
| 157 | Neuroendocrine neoplasm (HP:0100634) | 1.74316809 |
| 158 | Subcapsular cataract (HP:0000523) | 1.74243204 |
| 159 | Absent eyebrow (HP:0002223) | 1.73253078 |
| 160 | Congenital hip dislocation (HP:0001374) | 1.73226408 |
| 161 | Chronic diarrhea (HP:0002028) | 1.72638426 |
| 162 | Absent eyelashes (HP:0000561) | 1.72423751 |
| 163 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.72302843 |
| 164 | Retrobulbar optic neuritis (HP:0100654) | 1.72117108 |
| 165 | Optic neuritis (HP:0100653) | 1.72117108 |
| 166 | Frequent falls (HP:0002359) | 1.71222768 |
| 167 | Generalized aminoaciduria (HP:0002909) | 1.70650995 |
| 168 | Fibular aplasia (HP:0002990) | 1.67903869 |
| 169 | Polycythemia (HP:0001901) | 1.67688627 |
| 170 | Autoimmune hemolytic anemia (HP:0001890) | 1.64603999 |
| 171 | Facial cleft (HP:0002006) | 1.63784472 |
| 172 | Abnormal tarsal ossification (HP:0008369) | 1.63484018 |
| 173 | Acute hepatic failure (HP:0006554) | 1.62996968 |
| 174 | Peripheral demyelination (HP:0011096) | 1.62964194 |
| 175 | Broad thumb (HP:0011304) | 1.62905448 |
| 176 | Poor head control (HP:0002421) | 1.62885641 |
| 177 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.62435915 |
| 178 | Tinnitus (HP:0000360) | 1.62024331 |
| 179 | Hypertensive crisis (HP:0100735) | 1.61651338 |
| 180 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.61496591 |
| 181 | Gastrointestinal carcinoma (HP:0002672) | 1.61496591 |
| 182 | Hemoptysis (HP:0002105) | 1.61066839 |
| 183 | Abnormality of T cell physiology (HP:0011840) | 1.61065592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK24 | 8.46007835 |
| 2 | STK39 | 4.46820060 |
| 3 | WNK4 | 4.39172154 |
| 4 | ERN1 | 4.08694009 |
| 5 | CCNB1 | 4.03812562 |
| 6 | MAP3K2 | 4.02341261 |
| 7 | MAP4K1 | 3.03111964 |
| 8 | TYK2 | 2.84993410 |
| 9 | PINK1 | 2.68074669 |
| 10 | TRIB3 | 2.66235552 |
| 11 | TAOK3 | 2.63092700 |
| 12 | PKN2 | 2.43184652 |
| 13 | FGFR4 | 2.23714532 |
| 14 | MAPKAPK3 | 2.08724923 |
| 15 | WNK1 | 2.01886546 |
| 16 | TXK | 2.01161555 |
| 17 | BCKDK | 1.97911201 |
| 18 | ILK | 1.94165277 |
| 19 | MAP3K14 | 1.93841022 |
| 20 | CSK | 1.93241353 |
| 21 | STK10 | 1.89811355 |
| 22 | ZAP70 | 1.88440343 |
| 23 | SIK1 | 1.85529957 |
| 24 | PRPF4B | 1.81778441 |
| 25 | JAK3 | 1.80246807 |
| 26 | MAP3K10 | 1.78595973 |
| 27 | JAK1 | 1.75885657 |
| 28 | TBK1 | 1.75639479 |
| 29 | EEF2K | 1.75259509 |
| 30 | CDK12 | 1.71205963 |
| 31 | IRAK4 | 1.70687961 |
| 32 | IRAK3 | 1.67744284 |
| 33 | FRK | 1.67642218 |
| 34 | PTK6 | 1.63139327 |
| 35 | TGFBR2 | 1.53148682 |
| 36 | FLT3 | 1.51156452 |
| 37 | GRK6 | 1.49952780 |
| 38 | ITK | 1.44180343 |
| 39 | CDK6 | 1.43964998 |
| 40 | NEK9 | 1.43416568 |
| 41 | FGFR3 | 1.37374327 |
| 42 | CSF1R | 1.33359705 |
| 43 | ZAK | 1.31887141 |
| 44 | CAMK4 | 1.30372291 |
| 45 | EPHB1 | 1.22892708 |
| 46 | SCYL2 | 1.21273352 |
| 47 | JAK2 | 1.21222161 |
| 48 | IKBKE | 1.20376401 |
| 49 | CAMKK2 | 1.19337739 |
| 50 | MAP2K3 | 1.17273187 |
| 51 | SYK | 1.13758634 |
| 52 | CAMK1D | 1.13164950 |
| 53 | BTK | 1.10866184 |
| 54 | CAMK1 | 1.08807994 |
| 55 | LRRK2 | 1.05879959 |
| 56 | KIT | 1.04700362 |
| 57 | PIM1 | 1.03848549 |
| 58 | MAPK15 | 1.03527791 |
| 59 | PDGFRB | 1.03322217 |
| 60 | LCK | 1.03180787 |
| 61 | TRPM7 | 1.00534036 |
| 62 | CHEK2 | 0.99238914 |
| 63 | HCK | 0.97062187 |
| 64 | MAPK11 | 0.96226763 |
| 65 | MAP3K11 | 0.93552618 |
| 66 | IKBKB | 0.92826926 |
| 67 | PDGFRA | 0.90772709 |
| 68 | TEC | 0.88583776 |
| 69 | BLK | 0.88452389 |
| 70 | YES1 | 0.86068046 |
| 71 | MAPKAPK5 | 0.85642283 |
| 72 | PASK | 0.84902020 |
| 73 | CHUK | 0.80992247 |
| 74 | DYRK1B | 0.80703135 |
| 75 | MAP3K6 | 0.79883772 |
| 76 | BMX | 0.78886121 |
| 77 | ICK | 0.77253435 |
| 78 | CDK9 | 0.76271502 |
| 79 | LYN | 0.74469944 |
| 80 | CDK4 | 0.72724651 |
| 81 | RPS6KA4 | 0.72416455 |
| 82 | RIPK1 | 0.67952185 |
| 83 | EIF2AK3 | 0.67277866 |
| 84 | MST1R | 0.67151520 |
| 85 | FGR | 0.65781039 |
| 86 | MTOR | 0.65478781 |
| 87 | INSRR | 0.63771944 |
| 88 | EGFR | 0.61020512 |
| 89 | TNK2 | 0.60866223 |
| 90 | PIK3CG | 0.60405995 |
| 91 | STK3 | 0.59360676 |
| 92 | MATK | 0.56722726 |
| 93 | MAP3K8 | 0.56606766 |
| 94 | GSK3A | 0.56332998 |
| 95 | BMPR2 | 0.56291158 |
| 96 | MAPK4 | 0.56219395 |
| 97 | PRKCQ | 0.55909980 |
| 98 | MELK | 0.55867024 |
| 99 | TTN | 0.54208090 |
| 100 | MAP3K3 | 0.54095921 |
| 101 | CAMKK1 | 0.52361619 |
| 102 | SGK3 | 0.52090114 |
| 103 | HIPK2 | 0.51772838 |
| 104 | MAP3K7 | 0.51058588 |
| 105 | RPS6KA6 | 0.50440532 |
| 106 | PRKCH | 0.49742149 |
| 107 | CAMK1G | 0.49605887 |
| 108 | MARK3 | 0.49492409 |
| 109 | RPS6KA2 | 0.49435658 |
| 110 | RPS6KC1 | 0.49137724 |
| 111 | RPS6KL1 | 0.49137724 |
| 112 | NME2 | 0.48775404 |
| 113 | STK4 | 0.48198643 |
| 114 | RIPK4 | 0.47126147 |
| 115 | LATS1 | 0.47052837 |
| 116 | MAPK7 | 0.46320634 |
| 117 | ABL1 | 0.46169690 |
| 118 | PRKAA2 | 0.45973925 |
| 119 | RPS6KB2 | 0.45962545 |
| 120 | MAP3K13 | 0.43305960 |
| 121 | MST4 | 0.40151096 |
| 122 | MAPKAPK2 | 0.40032971 |
| 123 | SIK3 | 0.39353436 |
| 124 | INSR | 0.39327696 |
| 125 | ACVR1B | 0.36893164 |
| 126 | NTRK2 | 0.34274675 |
| 127 | MAPK12 | 0.33410203 |
| 128 | CDC7 | 0.33221815 |
| 129 | EIF2AK2 | 0.29408276 |
| 130 | IRAK1 | 0.29151271 |
| 131 | FER | 0.27947980 |
| 132 | TTK | 0.27072554 |
| 133 | DAPK2 | 0.26274904 |
| 134 | PDK1 | 0.20779932 |
| 135 | SGK2 | 0.20284120 |
| 136 | IRAK2 | 0.18602231 |
| 137 | PRKCD | 0.17737594 |
| 138 | TGFBR1 | 0.14862194 |
| 139 | RPS6KB1 | 0.14258046 |
| 140 | BMPR1B | 0.11009218 |
| 141 | CDC42BPA | 0.10997345 |
| 142 | SRPK1 | 0.10421572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.27022331 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.10469031 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.92283937 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.90086900 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.81228616 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73424348 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.69288577 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.50421931 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.47962226 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.47643837 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.34064480 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.23934855 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.14547711 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.98205156 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92105238 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.74876715 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72808736 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.72742974 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.61344292 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.55830577 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51270041 |
| 22 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.49141270 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47013085 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42777527 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41754439 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.40991383 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.36698270 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.33172783 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.30117204 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29734407 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29360964 |
| 32 | Lysine degradation_Homo sapiens_hsa00310 | 1.26960741 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.26675076 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.25674071 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.24011495 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.22408627 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20029513 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19324115 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19265563 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.17727900 |
| 41 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.17173504 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.15726330 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15642837 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15105811 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14375843 |
| 46 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.14246273 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13204585 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12535249 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12252347 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12023465 |
| 51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08844918 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07611487 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06987605 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05325038 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01434722 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01404151 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01214643 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00889709 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00315040 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00168935 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99762018 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99727469 |
| 63 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99239366 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.98139587 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.95578750 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.91484526 |
| 67 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87770854 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87657266 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87194864 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86581958 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.86077346 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84436677 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81977050 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81351937 |
| 75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81158013 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80842527 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79215132 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77332066 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76552821 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.75873196 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75730098 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74286900 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73135795 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72302455 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.71727225 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70670289 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69998440 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69486353 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68703872 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67884530 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67163096 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.65977048 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64844252 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64603639 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63916502 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63114325 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.62779331 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62154422 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.62097792 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61813960 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61637489 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.60418869 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60316690 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59767383 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58867843 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58363114 |
| 107 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56979635 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56819780 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56600322 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.56166400 |
| 111 | Tuberculosis_Homo sapiens_hsa05152 | 0.56048492 |
| 112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55134309 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53414308 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.52744336 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52304604 |
| 116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51941393 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51902018 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.51195701 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.49935756 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49489048 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48738870 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.48252822 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48235544 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47721573 |
| 125 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47179294 |
| 126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46144924 |
| 127 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.46071629 |
| 128 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45550301 |
| 129 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45441400 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44837529 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.44431698 |
| 132 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43672655 |
| 133 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43224838 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42521092 |
| 135 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41463899 |
| 136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41192130 |
| 137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39793118 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39512261 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39416783 |
| 140 | Prostate cancer_Homo sapiens_hsa05215 | 0.39097988 |
| 141 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38415949 |
| 142 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37725758 |
| 143 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36927443 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | 0.36764184 |
| 145 | Salivary secretion_Homo sapiens_hsa04970 | 0.36685887 |
| 146 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34479055 |
| 147 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34349162 |
| 148 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33592672 |
| 149 | Long-term depression_Homo sapiens_hsa04730 | 0.32575044 |
| 150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31877525 |
| 151 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.31598162 |
| 152 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.31491847 |
| 153 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.31067979 |
| 154 | Phototransduction_Homo sapiens_hsa04744 | 0.30231003 |

